Reposted by Madeline Wood Alexander
Scientists consider how age at menopause and history of hormone therapy interact with biomarkers of synaptic health (β-amyloid and tau) to contribute to Alzheimer’s disease and dementia in women. #WomensHealth
Learn more in #ScienceAdvances: scim.ag/3XJ8H5n
scim.ag
The interplay between age at menopause and synaptic integrity on Alzheimer’s disease risk in women
Earlier age at menopause exacerbates synapse-related vulnerability to cognitive decline and tau tangles.